HomeCompareIMEXF vs PEP

IMEXF vs PEP: Dividend Comparison 2026

IMEXF yields 2000000.00% · PEP yields 3.69%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMEXF wins by $4.879226400974806e+39M in total portfolio value
10 years
IMEXF
IMEXF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full IMEXF calculator →
PEP
PepsiCo Inc.
● Live price
3.69%
Share price
$146.80
Annual div
$5.42
5Y div CAGR
6.7%
Payout ratio
72%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$1,034.52
Full PEP calculator →

Portfolio growth — IMEXF vs PEP

📍 IMEXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMEXFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMEXF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMEXF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMEXF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
PEP
Annual income on $10K today (after 15% tax)
$313.83/yr
After 10yr DRIP, annual income (after tax)
$879.34/yr
At 15% tax rate, IMEXF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMEXF + PEP for your $10,000?

IMEXF: 50%PEP: 50%
100% PEP50/50100% IMEXF
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

IMEXF
No analyst data
Altman Z
-72.9
Piotroski
1/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+17.5% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMEXF buys
0
PEP buys
0
No recent congressional trades found for IMEXF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMEXFPEP
Forward yield2000000.00%3.69%
Annual dividend / share$2.00$5.42
Payout ratio50%72%
1-year div growth0%7.1%
5-year div CAGR0%6.7%
Portfolio after 10y$4.879226400974806e+39M$21.5K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$1,034.52
Total dividends collected$4.879195005460081e+39M$6.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IMEXF vs PEP ($10,000, DRIP)

YearIMEXF PortfolioIMEXF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,734$393.95+$200.00MIMEXF
2$3,738,731,768,458$3,738,517,757,009.35$11,535$436.36+$3738731.76MIMEXF
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,411$483.90+$65315062866.92MIMEXF
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,371$537.26+$1066400830062625.00MIMEXF
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$14,422$597.26+$16272182796453826560.00MIMEXF
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$15,578$664.81+$2.3205424011366188e+23MIMEXF
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$16,848$740.97+$3.0927990661046884e+27MIMEXF
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$18,248$826.99+$3.8524105697352695e+31MIMEXF
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$19,793$924.28+$4.484688260147987e+35MIMEXF
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$21,500$1,034.52+$4.879226400974806e+39MIMEXF

IMEXF vs PEP: Complete Analysis 2026

IMEXFStock

Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. The company is developing the i/Blue Imaging System to meet the BLC needs of urologists. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada.

Full IMEXF Calculator →

PEPConsumer Staples

PepsiCo is a Dividend King with 52+ consecutive years of increases. Its diversified portfolio spans beverages and snacks via brands including Pepsi, Gatorade, Lay's, and Quaker. Snack food exposure provides more stable volumes than pure beverages. International expansion in emerging markets drives long-term growth.

Full PEP Calculator →
📬

Get this IMEXF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMEXF vs SCHDIMEXF vs JEPIIMEXF vs OIMEXF vs KOIMEXF vs MAINIMEXF vs MOIMEXF vs PMIMEXF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.